M. Arthus

发表

Three families with autosomal dominant nephrogenic diabetes insipidus caused by aquaporin-2 mutations in the C-terminus.

F. Marumo, D. Bichet, Y. Terada, 2001, American journal of human genetics.

Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus.

I. Nabi, D. Bichet, M. Bouvier, 2001, Biochemistry.

Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus.

P. Giampietro, D. Bichet, S. Simonetti, 1994, American journal of human genetics.

Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype.

N. Cotte, C. Antignac, G. Alonso, 1998, Journal of the American Society of Nephrology : JASN.

Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants.

S. Angers, D. Bichet, M. Bouvier, 2000, The Journal of clinical investigation.

Rolipram, a phosphodiesterase inhibitor, in the treatment of two male patients with congenital nephrogenic diabetes insipidus.

D. Bichet, M. Lonergan, M. Arthus, 1990, Nephron.

Mutations in the vasopressin V2 receptor gene in families with nephrogenic diabetes insipidus and functional expression of the Q-2 mutant.

D. Bichet, M. Birnbaumer, A. Seibold, 1994, Cellular and molecular biology.

Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.

D. Bichet, M. Arthus, M. Lonergan, 1988, The New England journal of medicine.

1-Desamino[8-D-Arginine]Vasopressin (dDAVP) Decreases Blood Pressure and Increases Pulse Rate in Normal Individuals

D. Bichet, M. Lonergan, M. Arthus, 1988, Thrombosis and Haemostasis.

An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex.

P. Sluijs, D. Bichet, P. Deen, 1998, The Journal of clinical investigation.

Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus.

D. Bichet, S. Sasaki, S. Sasaki, 2000, Journal of the American Society of Nephrology : JASN.

Human platelet fraction arginine-vasopressin. Potential physiological role.

D. Bichet, M. Lonergan, M. Arthus, 1987, The Journal of clinical investigation.

Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Evidence for a pre-cyclic AMP V2 receptor defective mechanism.

D. Hirsch, D. Bichet, M. Arthus, 1989, Kidney international.

X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis.

M. Gregory, D. Bichet, G. Hendy, 1993, The Journal of clinical investigation.

Platelet vasopressin receptors in patients with congenital nephrogenic diabetes insipidus.

D. Bichet, M. Lonergan, M. Arthus, 1991, Kidney international.

X-linked nephrogenic diabetes insipidus: from the ship Hopewell to RFLP studies.

Z. Pausova, D. Bichet, G. Hendy, 1992, American journal of human genetics.

Is testing with dDAVP useful in detecting carriers of the nephrogenic diabetes insipidus gene?

D. Bichet, M. Lonergan, M. Arthus, 1991, Nephron.